Elementary Research on Clinical Significance of Human Tissue Kallikrein Gene 5 Expression in Breast Cancer Tissues

LI Mei-fang,HE Jian-rong,SHEN Kun-wei,LI Ya-fen,CHEN Wei-guo,ZHU Li,HAN Bao-san,LIU Bing-ya,ZHU Zheng-gang

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2010.16.011

2010-01-01

Abstract:OBJECTIVE:Initially to investigate expression and clinical significance of human kallikrein gene 5 in breast cancer,as well as to explore the mechanism of its abnormal expression in breast cancer.METHODS:A total of 61 cases of breast cancer tissues and adjacent tissues were collected.Thirty cases of fibroadenoma tissues were also collected in order to compare with breast cancer.The expression of human tissue kallikrein 5 in breast cancer tissues and fibroadenoma tissues was evaluated by quantitative real-time RT-PCR and Western-blotting methods.The methylation-specific PCR was used to demonstrate the correlation between exon 3 hypermethylation and the loss of KLK5 expression in primary tumors.RESULTS:KLK5 was downregulated in breast cancer tissues (Z=5.24,P0.000 1) and this phenomenon was not found in fibroadenoma(Z=1.347,P=0.178).The expression of KLK5 was lower in breast cancer than that in fibroadenoma(Z=4.449,P0.001).The expression of KLK5 was associated with the menses status(F=26.928,P0.001),primary tumor size(F=6.267,P=0.012),node status(F=3.856,P=0.050) and stage(F=7.863,P=0.020).The exon 3 hypermethylation of KLK5 existed in breast cancer.CONCLUSIONS:KLK5 is downregulated in breast cancer and may be a favorable tumor biomarker.The downregulation of KLK5 in breast cancer may be associated with the exon 3 hypermethylation.